مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: drug dose reduction, drug substitution, drug withdrawal, end stage renal disease/su [Surgery], end stage renal disease/th [Therapy], fever/co [Complication], gastroscopy, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], Haemophilus parainfluenzae, hemolysis/di [Diagnosis], hemolysis/si [Side Effect], HLA matching, human, hypercholesterolemia, hypertension, hypotension/co [Complication], hypotension/dt [Drug Therapy], immunosuppressive treatment, intensive care, kidney biopsy, kidney cortex necrosis/di [Diagnosis], kidney pancreas transplantation, leg thrombosis/di [Diagnosis], leg thrombosis/dt [Drug Therapy], leukocyte count, low drug dose, male, medical history, middle aged, pancytopenia/si [Side Effect], paronychia/co [Complication], paronychia/dt [Drug Therapy], peritoneal dialysis, plasma exchange, Pseudomonas infection/co [Complication], Pseudomonas infection/dt [Drug Therapy], reflux esophagitis/di [Diagnosis], remission, review, sigmoidoscopy, thrombocyte count, thrombosis/dt [Drug Therapy], thrombosis/pc [Prevention], thrombosis prevention, thrombotic thrombocytopenic purpura/co [Complication], thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/dt [Drug Therapy], thrombotic thrombocytopenic purpura/th [Therapy], triacylglycerol lipase blood level, urinary tract infection/co [Complication], urinary tract infection/dt [Drug Therapy], vomiting/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], basiliximab/cb [Drug Combination], basiliximab/dt [Drug Therapy], beta2 glycoprotein 1/ec [Endogenous Compound], cardiolipin antibody/ec [Endogenous Compound], corticosteroid/cb [Drug Combination], corticosteroid/dt [Drug Therapy], creatinine/ec [Endogenous Compound], eculizumab/ae [Adverse Drug Reaction], eculizumab/dt [Drug Therapy], eculizumab/iv [Intravenous Drug Administration], enoxaparin/dt [Drug Therapy], everolimus/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], flucloxacillin/iv [Intravenous Drug Administration], HLA antibody/ec [Endogenous Compound], inotropic agent/dt [Drug Therapy], leukocyte antigen/ec [Endogenous Compound], mycophenolic acid/cb [Drug Combination], mycophenolic acid/dt [Drug Therapy], novel erythropoiesis stimulating protein/dt [Drug Therapy], phospholipid antibody/ec [Endogenous Compound], piperacillin plus tazobactam/dt [Drug Therapy], prednisolone/dt [Drug Therapy], tacrolimus/cb [Drug Combination], tacrolimus/dt [Drug Therapy], thymocyte antibody/dt [Drug Therapy], triacylglycerol lipase/ec [Endogenous Compound], warfarin/dt [Drug Therapy], catheter/am [Adverse Device Effect], human tissue, adult, anemia/di [Diagnosis], anemia/dt [Drug Therapy], antibody titer, bacterium identification, biochemical analysis, bone marrow biopsy, bone marrow suppression/di [Diagnosis], case report, catheter, creatinine blood level, deep vein thrombosis/di [Diagnosis], deep vein thrombosis/dt [Drug Therapy], diabetic retinopathy, diarrhea/co [Complication], diarrhea/si [Side Effect], Doppler flowmetry, drug dose increase, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39529Test
Nephrology
Click here for full text options
LibKey Link

مصطلحات الفهرس: peritoneal dialysis, randomized controlled trial, rating scale, review, single blind procedure, surgical patient, visual analog scale, novel erythropoiesis stimulating protein/ae [Adverse Drug Reaction], novel erythropoiesis stimulating protein/ct [Clinical Trial], novel erythropoiesis stimulating protein/cm [Drug Comparison], novel erythropoiesis stimulating protein/dt [Drug Therapy], novel erythropoiesis stimulating protein/sc [Subcutaneous Drug Administration], recombinant erythropoietin/ae [Adverse Drug Reaction], recombinant erythropoietin/ct [Clinical Trial], recombinant erythropoietin/cm [Drug Comparison], recombinant erythropoietin/dt [Drug Therapy], recombinant erythropoietin/sc [Subcutaneous Drug Administration], kidney transplantation, adult, aged, anemia/co [Complication], anemia/dt [Drug Therapy], chronic kidney disease, clinical article, clinical trial, comparative study, controlled clinical trial, controlled study, crossover procedure, drug preference, drug response, female, hemodialysis patient, human, injection site pain/si [Side Effect], injection site pain/di [Diagnosis], male, multicenter study, pain assessment, pain threshold, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31592Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: priority journal, pure red cell anemia/dt [Drug Therapy], pure red cell anemia/si [Side Effect], pure red cell anemia/th [Therapy], treatment response, calcineurin inhibitor/cm [Drug Comparison], calcineurin inhibitor/dt [Drug Therapy], continuous erythropoiesis receptor activator/dt [Drug Therapy], corticosteroid derivative/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], cyclosporin/cb [Drug Combination], cyclosporin/dt [Drug Therapy], erythropoietin/ec [Endogenous Compound], immunoglobulin/cm [Drug Comparison], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], novel erythropoiesis stimulating protein/dt [Drug Therapy], recombinant erythropoietin/ae [Adverse Drug Reaction], recombinant erythropoietin/dt [Drug Therapy], recombinant erythropoietin/iv [Intravenous Drug Administration], recombinant erythropoietin/sc [Subcutaneous Drug Administration], rituximab/dt [Drug Therapy], steroid/cb [Drug Combination], unclassified drug, erypro, steroid/dt [Drug Therapy], anemia/dt [Drug Therapy], chronic kidney disease, disease association, drug withdrawal, editorial, erythrocyte transfusion, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], human, immune response, immunosuppressive treatment, nonhuman, plasmapheresis, Editorial

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31661Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: hemoglobin blood level, human, hypertension/si [Side Effect], major clinical study, male, multicenter study, phase 3 clinical trial, priority journal, randomized controlled trial, rhinopharyngitis/si [Side Effect], treatment duration, treatment outcome, unspecified side effect/si [Side Effect], upper respiratory tract infection/si [Side Effect], vomiting/si [Side Effect], continuous erythropoiesis receptor activator/ae [Adverse Drug Reaction], continuous erythropoiesis receptor activator/ct [Clinical Trial], continuous erythropoiesis receptor activator/cm [Drug Comparison], continuous erythropoiesis receptor activator/do [Drug Dose], continuous erythropoiesis receptor activator/dt [Drug Therapy], continuous erythropoiesis receptor activator/iv [Intravenous Drug Administration], hemoglobin/ec [Endogenous Compound], novel erythropoiesis stimulating protein/ae [Adverse Drug Reaction], novel erythropoiesis stimulating protein/ct [Clinical Trial], novel erythropoiesis stimulating protein/cm [Drug Comparison], novel erythropoiesis stimulating protein/dt [Drug Therapy], novel erythropoiesis stimulating protein/iv [Intravenous Drug Administration], influenza/si [Side Effect], adult, anemia/dt [Drug Therapy], angina pectoris/si [Side Effect], article, backache/si [Side Effect], chronic kidney disease/th [Therapy], clinical trial, controlled clinical trial, controlled study, coughing/si [Side Effect], diarrhea/si [Side Effect], drug dose titration, drug efficacy, drug fatality/si [Side Effect], drug safety, drug tolerability, drug withdrawal, female, fever/si [Side Effect], fluid overload/si [Side Effect], headache/si [Side Effect], hemodialysis, hemodialysis patient, Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: priority journal, randomized controlled trial, rhinopharyngitis/si [Side Effect], treatment duration, urinary tract infection/si [Side Effect], hemoglobin/ec [Endogenous Compound], macrogol derivative/pr [Pharmaceutics], novel erythropoiesis stimulating protein/ae [Adverse Drug Reaction], novel erythropoiesis stimulating protein/ct [Clinical Trial], novel erythropoiesis stimulating protein/cm [Drug Comparison], novel erythropoiesis stimulating protein/do [Drug Dose], novel erythropoiesis stimulating protein/dt [Drug Therapy], novel erythropoiesis stimulating protein/iv [Intravenous Drug Administration], recombinant erythropoietin/ae [Adverse Drug Reaction], recombinant erythropoietin/ct [Clinical Trial], recombinant erythropoietin/cm [Drug Comparison], recombinant erythropoietin/do [Drug Dose], recombinant erythropoietin/dt [Drug Therapy], recombinant erythropoietin/pr [Pharmaceutics], unclassified drug, methoxypolyethylene glycol/pr [Pharmaceutics], hypotension/si [Side Effect], adult, aged, anemia/dt [Drug Therapy], article, bronchitis/si [Side Effect], chronic kidney disease/th [Therapy], clinical trial, controlled clinical trial, controlled study, diarrhea/si [Side Effect], drug dose increase, drug efficacy, drug withdrawal, female, follow up, hemodialysis patient, hemoglobin blood level, human, hypertension/si [Side Effect], infection/si [Side Effect], maintenance therapy, major clinical study, male, mortality, multicenter study, muscle spasm/si [Side Effect], Article

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: drug half life, drug structure, health care cost, health care personnel, homeostasis, human, intermethod comparison, mortality, patient compliance, priority journal, protein function, quality of life, review, treatment duration, continuous erythropoiesis receptor activator/ct [Clinical Trial], continuous erythropoiesis receptor activator/dt [Drug Therapy], continuous erythropoiesis receptor activator/pk [Pharmacokinetics], ferric gluconate/dt [Drug Therapy], ferric hydroxide sucrose/cm [Drug Comparison], ferric hydroxide sucrose/dt [Drug Therapy], ferric hydroxide sucrose/iv [Intravenous Drug Administration], ferric hydroxide sucrose/pd [Pharmacology], hemoglobin/ec [Endogenous Compound], hepcidin/ec [Endogenous Compound], iron/cm [Drug Comparison], iron/dt [Drug Therapy], iron/iv [Intravenous Drug Administration], iron/po [Oral Drug Administration], iron/pd [Pharmacology], iron dextran/dt [Drug Therapy], iron dextran/iv [Intravenous Drug Administration], iron dextran/pd [Pharmacology], iron salt/cm [Drug Comparison], novel erythropoiesis stimulating protein/cm [Drug Comparison], novel erythropoiesis stimulating protein/ad [Drug Administration], novel erythropoiesis stimulating protein/an [Drug Analysis], novel erythropoiesis stimulating protein/do [Drug Dose], novel erythropoiesis stimulating protein/dt [Drug Therapy], novel erythropoiesis stimulating protein/iv [Intravenous Drug Administration], novel erythropoiesis stimulating protein/pk [Pharmacokinetics], novel erythropoiesis stimulating protein/pd [Pharmacology], novel erythropoiesis stimulating protein/sc [Subcutaneous Drug Administration], recombinant erythropoietin/cm [Drug Comparison], recombinant erythropoietin/ad [Drug Administration], recombinant erythropoietin/an [Drug Analysis], recombinant erythropoietin/do [Drug Dose], recombinant erythropoietin/dt [Drug Therapy], recombinant erythropoietin/pk [Pharmacokinetics], recombinant erythropoietin/pd [Pharmacology], recombinant erythropoietin/sc [Subcutaneous Drug Administration], dosage schedule comparison, recombinant erythropoietin/iv [Intravenous Drug Administration], drug tolerability, erythropoiesis, anemia/co [Complication], anemia/dt [Drug Therapy], chronic kidney disease/dm [Disease Management], chronotherapy, clinical practice, clinical trial, dialysis, disease association, drug dose increase, drug efficacy, drug elimination, Review

URL: Click here for full text options
LibKey Link

مصطلحات الفهرس: dose response, calcinosis/si [Side Effect], clinical protocol, constipation/si [Side Effect], controlled study, diarrhea/si [Side Effect], drug cost, drug efficacy, drug safety, faintness/si [Side Effect], female, ferritin blood level, gastrointestinal symptom/si [Side Effect], heart arrest/si [Side Effect], heart infarction/si [Side Effect], hematological parameters, hemodialysis patient, hemoglobin blood level, human, hypercalcemia/si [Side Effect], intention to treat analysis, iron storage, kidney failure/co [Complication], kidney failure/th [Therapy], liver cyst/si [Side Effect], major clinical study, male, multicenter study, open study, outcome assessment, peritoneal dialysis, peritonitis/si [Side Effect], phase 4 clinical trial, priority journal, prospective study, randomized controlled trial, respiratory tract disease/si [Side Effect], restless legs syndrome/si [Side Effect], supplementation, treatment duration, ulcer/si [Side Effect], unspecified side effect/si [Side Effect], unstable angina pectoris/si [Side Effect], urinary tract disease/si [Side Effect], vomiting/si [Side Effect], weakness/si [Side Effect], ferritin/ec [Endogenous Compound], ferrous sulfate/ae [Adverse Drug Reaction], ferrous sulfate/ct [Clinical Trial], ferrous sulfate/cm [Drug Comparison], ferrous sulfate/dt [Drug Therapy], ferrous sulfate/po [Oral Drug Administration], ferrous sulfate/pr [Pharmaceutics], hemoglobin/ec [Endogenous Compound], iron saccharate/ae [Adverse Drug Reaction], iron saccharate/ct [Clinical Trial], iron saccharate/cm [Drug Comparison], iron saccharate/dt [Drug Therapy], iron saccharate/po [Oral Drug Administration], iron saccharate/pr [Pharmaceutics], novel erythropoiesis stimulating protein/dt [Drug Therapy], transferrin/ec [Endogenous Compound], unclassified drug, transferrin saturation, proferrin es, abdominal pain/si [Side Effect], adult, anemia/co [Complication], anemia/dm [Disease Management], anemia/dt [Drug Therapy], article, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28181Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: peritoneal dialysis, randomized controlled trial, rating scale, review, single blind procedure, surgical patient, visual analog scale, novel erythropoiesis stimulating protein/ae [Adverse Drug Reaction], novel erythropoiesis stimulating protein/ct [Clinical Trial], novel erythropoiesis stimulating protein/cm [Drug Comparison], novel erythropoiesis stimulating protein/dt [Drug Therapy], novel erythropoiesis stimulating protein/sc [Subcutaneous Drug Administration], recombinant erythropoietin/ae [Adverse Drug Reaction], recombinant erythropoietin/ct [Clinical Trial], recombinant erythropoietin/cm [Drug Comparison], recombinant erythropoietin/dt [Drug Therapy], recombinant erythropoietin/sc [Subcutaneous Drug Administration], kidney transplantation, adult, aged, anemia/co [Complication], anemia/dt [Drug Therapy], chronic kidney disease, clinical article, clinical trial, comparative study, controlled clinical trial, controlled study, crossover procedure, drug preference, drug response, female, hemodialysis patient, human, injection site pain/si [Side Effect], injection site pain/di [Diagnosis], male, multicenter study, pain assessment, pain threshold, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31592Test
LibKey Link

مصطلحات الفهرس: priority journal, pure red cell anemia/dt [Drug Therapy], pure red cell anemia/si [Side Effect], pure red cell anemia/th [Therapy], treatment response, calcineurin inhibitor/cm [Drug Comparison], calcineurin inhibitor/dt [Drug Therapy], continuous erythropoiesis receptor activator/dt [Drug Therapy], corticosteroid derivative/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/dt [Drug Therapy], cyclosporin/cb [Drug Combination], cyclosporin/dt [Drug Therapy], erythropoietin/ec [Endogenous Compound], immunoglobulin/cm [Drug Comparison], immunoglobulin/dt [Drug Therapy], immunoglobulin/iv [Intravenous Drug Administration], novel erythropoiesis stimulating protein/dt [Drug Therapy], recombinant erythropoietin/ae [Adverse Drug Reaction], recombinant erythropoietin/dt [Drug Therapy], recombinant erythropoietin/iv [Intravenous Drug Administration], recombinant erythropoietin/sc [Subcutaneous Drug Administration], rituximab/dt [Drug Therapy], steroid/cb [Drug Combination], unclassified drug, erypro, steroid/dt [Drug Therapy], anemia/dt [Drug Therapy], chronic kidney disease, disease association, drug withdrawal, editorial, erythrocyte transfusion, graft versus host reaction/dt [Drug Therapy], graft versus host reaction/pc [Prevention], human, immune response, immunosuppressive treatment, nonhuman, plasmapheresis, Editorial

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31661Test
LibKey Link